1. Impact of HMGB1 on cancer development and therapeutic insights focused on CNS malignancy
   Sucharita Patra et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
2. High LC3/Beclin Expression Correlates with Poor Survival in Glioma: a Definitive Role for Autophagy as Evidenced by In Vitro Autophagic Flux
   Padmakrishnan CJ et al, 2019, Pathology & Oncology Research CrossRef
3. Overexpression of high mobility group box 1 (HMGB1) has no correlation with the prognosis in glioma
   Liyun Jia et al, 2019, Biomarkers in Medicine CrossRef
4. Pivotal role of high-mobility group box 1 (HMGB1) signaling pathways in glioma development and progression
   Efthalia Angelopoulou et al, 2016, Journal of Molecular Medicine CrossRef
5. Single Nucleotide Polymorphisms in HMGB1 Correlate with Lung Cancer Risk in the Northeast Chinese Han Population
   Min Jiang et al, 2018, Molecules CrossRef
6. Temozolomide Treatment Induces HMGB1 to Promote the Formation of Glioma Stem Cells via the TLR2/NEAT1/Wnt Pathway in Glioblastoma
   Xiang-Yu Gao et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
7. Hypoxia-induced HMGB1 promotes glioma stem cells self-renewal and tumorigenicity via RAGE
   Cuifang Ye et al, 2022, iScience CrossRef
8. Starvation insult induces the translocation of high mobility group box 1 to cytosolic compartments in glioma
   Xiaohang Cui et al, 2023, Oncology Reports CrossRef
9. The role of high‐mobility group protein box 1 in lung cancer
   Xiao‐Jin Wu et al, 2018, Journal of Cellular Biochemistry CrossRef
10. HMGB1/RAGE axis in tumor development: unraveling its significance
    Anqi Fan et al, 2024, Frontiers in Oncology CrossRef
11. High-mobility group box 1 is a promising diagnostic and therapeutic monitoring biomarker in Cancers: A review
    Seidu A. Richard et al, 2018, AIMS Molecular Science CrossRef
12. High expression of the HMGB1–TLR4 axis and its downstream signaling factors in patients with Parkinson's disease and the relationship of pathological staging
    Yi Yang et al, 2018, Brain and Behavior CrossRef
13. Cytokine Profile in Development of Glioblastoma in Relation to Healthy Individuals
    Pawel Jarmuzek et al, 2023, International Journal of Molecular Sciences CrossRef
14. The association between high mobility group box 1 chromatin protein and mitotic chromosomes in glioma cells
    Liyun Jia et al, 2019, Oncology Letters CrossRef
15. Retracted: MCL1 gene silencing promotes senescence and apoptosis of glioma cells via inhibition of the PI3K/Akt signaling pathway
    Dong‐Mei Wu et al, 2019, IUBMB Life CrossRef
16. The dual role and therapeutic potential of high-mobility group box 1 in cancer
    Si-Jia He et al, 2017, Oncotarget CrossRef
17. A novel therapeutic strategy of multimodal nanoconjugates for state-of-the-art brain tumor phototherapy
    Hyung Shik Kim et al, 2022, Journal of Nanobiotechnology CrossRef
18. Inhibition of DAMP actions in the tumoral microenvironment using lactoferrin-glycyrrhizin conjugate for glioblastoma therapy
    Hyung Shik Kim et al, 2023, Biomaterials Research CrossRef